1 / 1

Treatment Protocol for SCLC with CDDP and XRT in Good Responders

This protocol outlines a treatment strategy for patients with Small Cell Lung Cancer (SCLC), specifically focusing on those classified as good responders. The regimen includes administering three cycles of CDDP (cisplatin), along with radiation therapy (XRT), at a dose of 45 Gy over 30 fractions (BID dosing), for patients with a performance status of 0-1. Additional treatment considerations include PCI (prophylactic cranial irradiation) for patients who respond favorably to initial therapy.

mignon
Télécharger la présentation

Treatment Protocol for SCLC with CDDP and XRT in Good Responders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. R R Group A A A EP+CDDP N N EP+CDDP 3 cycles* LD - - D D 1 cycle SCLC O O XRT (BID) M M PS 0-1 45 Gy/30 fx I I Group B Z Z CPT CPT - - 11+CDDP 11+CDDP E E 3 cycles* 3 cycles* *PCI for good responders

More Related